Showing results (1611-1620 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 2, 2016
The Impact of Different DCE-Based Approaches When Anchoring Utility ScoresRichard Norman, Brendan Mulhern, Rosalie VineyPharmacoeconomics|February 3, 2016
Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for HealthSalah Ghabri, Françoise F Hamers, Jean Michel JosselinPharmacoeconomics|September 22, 2017
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related ResearchThea van Asselt, Bram Ramaekers, Isaac Corro Ramos, et al.Pharmacoeconomics|September 7, 2017
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile InfectionHannah E Burton, Stephen A Mitchell, Maureen WattPharmacoeconomics|November 11, 2016
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision AnalysisHenk Broekhuizen, Maarten J IJzerman, A Brett Hauber, et al.Pharmacoeconomics|August 25, 2017
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and ImplicationsAlessandra Ferrario, Diāna Arāja, Tomasz Bochenek, et al.Pharmacoeconomics|January 1, 2017
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UKC Rinciog, M Watkins, S Chang, et al.Pharmacoeconomics|March 5, 2018
Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, Jean Hamilton, et al.Pharmacoeconomics|June 28, 2018
Costs of Invasive Meningococcal Disease: A Global Systematic ReviewBing Wang, Renee Santoreneos, Hossein Afzali, et al.Pharmacoeconomics|October 8, 2018
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Nigel Armstrong, Bram L T Ramaekers, et al.Pageof 336